deprescribing.org
@deprescribing.bsky.social
We create guidelines and tools to support healthcare providers and patients in #deprescribing.🇨🇦 LinkedIn:linkedin.com/company/deprescribing-org
Could Artificial Intelligence (AI) help or harm efforts to reduce low-value tests and treatments?
📅 Join @choosingwiselyca.bsky.social on Feb 12, 2026 at 12:00 pm ET to learn more about the role of AI in addressing overuse in healthcare.
👇 Register here:
buff.ly/EGfXzmx
📅 Join @choosingwiselyca.bsky.social on Feb 12, 2026 at 12:00 pm ET to learn more about the role of AI in addressing overuse in healthcare.
👇 Register here:
buff.ly/EGfXzmx
February 11, 2026 at 5:01 PM
Could Artificial Intelligence (AI) help or harm efforts to reduce low-value tests and treatments?
📅 Join @choosingwiselyca.bsky.social on Feb 12, 2026 at 12:00 pm ET to learn more about the role of AI in addressing overuse in healthcare.
👇 Register here:
buff.ly/EGfXzmx
📅 Join @choosingwiselyca.bsky.social on Feb 12, 2026 at 12:00 pm ET to learn more about the role of AI in addressing overuse in healthcare.
👇 Register here:
buff.ly/EGfXzmx
Check out a Virtual Seminar on "Resetting the DIAL on diabetes management in long-term care homes" on Tuesday, February 17 from 12:00 to 1:00 p.m. ET with @lisamccarthy.bsky.social & @ilianalega.bsky.social
⛓️💥 Register here: buff.ly/bP3POSt
⛓️💥 Register here: buff.ly/bP3POSt
February 6, 2026 at 5:01 PM
Check out a Virtual Seminar on "Resetting the DIAL on diabetes management in long-term care homes" on Tuesday, February 17 from 12:00 to 1:00 p.m. ET with @lisamccarthy.bsky.social & @ilianalega.bsky.social
⛓️💥 Register here: buff.ly/bP3POSt
⛓️💥 Register here: buff.ly/bP3POSt
A Clinical Trial published in @jama.com finds Electronic Health Record (EHR) prompts informed by behavioural-science can significantly increase the rates of #deprescribing of potentially inappropriate medications used by older adults:
buff.ly/uF489QP
buff.ly/uF489QP
February 3, 2026 at 5:02 PM
A Clinical Trial published in @jama.com finds Electronic Health Record (EHR) prompts informed by behavioural-science can significantly increase the rates of #deprescribing of potentially inappropriate medications used by older adults:
buff.ly/uF489QP
buff.ly/uF489QP
Great editorial in @bmj.com written by our deprescribing.org Co-Director Wade Thompson, along with Anton Pottegård!
buff.ly/DfygbLS
While PPI use without an indication is a recognized problem, we should also avoid using low-quality evidence to justify #deprescribing decisions.
buff.ly/DfygbLS
While PPI use without an indication is a recognized problem, we should also avoid using low-quality evidence to justify #deprescribing decisions.
January 30, 2026 at 5:03 PM
Great editorial in @bmj.com written by our deprescribing.org Co-Director Wade Thompson, along with Anton Pottegård!
buff.ly/DfygbLS
While PPI use without an indication is a recognized problem, we should also avoid using low-quality evidence to justify #deprescribing decisions.
buff.ly/DfygbLS
While PPI use without an indication is a recognized problem, we should also avoid using low-quality evidence to justify #deprescribing decisions.
January is Alzheimer's Awareness Month in Canada!
By 2030, researchers project that nearly 1 million people in Canada could be living with dementia.
No one should face dementia alone.
Learn more about dementia and how you can help at:
alzheimer.ca/en
#ForgetNoOne
By 2030, researchers project that nearly 1 million people in Canada could be living with dementia.
No one should face dementia alone.
Learn more about dementia and how you can help at:
alzheimer.ca/en
#ForgetNoOne
January 27, 2026 at 5:09 PM
January is Alzheimer's Awareness Month in Canada!
By 2030, researchers project that nearly 1 million people in Canada could be living with dementia.
No one should face dementia alone.
Learn more about dementia and how you can help at:
alzheimer.ca/en
#ForgetNoOne
By 2030, researchers project that nearly 1 million people in Canada could be living with dementia.
No one should face dementia alone.
Learn more about dementia and how you can help at:
alzheimer.ca/en
#ForgetNoOne
New research letter published in @jama.com showed an encouraging decline in potentially inappropriate CNS-active prescriptions from 2013 to 2021 in United States Medicare data. 📉
buff.ly/OgmSJbr
However, more work still needs to be done to further reduce the use of CNS-active PIMs.
buff.ly/OgmSJbr
However, more work still needs to be done to further reduce the use of CNS-active PIMs.
January 23, 2026 at 5:01 PM
New research letter published in @jama.com showed an encouraging decline in potentially inappropriate CNS-active prescriptions from 2013 to 2021 in United States Medicare data. 📉
buff.ly/OgmSJbr
However, more work still needs to be done to further reduce the use of CNS-active PIMs.
buff.ly/OgmSJbr
However, more work still needs to be done to further reduce the use of CNS-active PIMs.
Reposted by deprescribing.org
Register to the next Int'l Deprescribing Journal Club on Feb 26!
Hosted by the Portuguese Deprescribing Network, Dr. Teixeira Rodrigues presents the design & implementation of C-SENIoR, an interprofessional (GP & pharm) deprescribing model to optimise PPI use in older adults.
tinyurl.com/bdhh5kpp
Hosted by the Portuguese Deprescribing Network, Dr. Teixeira Rodrigues presents the design & implementation of C-SENIoR, an interprofessional (GP & pharm) deprescribing model to optimise PPI use in older adults.
tinyurl.com/bdhh5kpp
January 12, 2026 at 3:05 PM
Register to the next Int'l Deprescribing Journal Club on Feb 26!
Hosted by the Portuguese Deprescribing Network, Dr. Teixeira Rodrigues presents the design & implementation of C-SENIoR, an interprofessional (GP & pharm) deprescribing model to optimise PPI use in older adults.
tinyurl.com/bdhh5kpp
Hosted by the Portuguese Deprescribing Network, Dr. Teixeira Rodrigues presents the design & implementation of C-SENIoR, an interprofessional (GP & pharm) deprescribing model to optimise PPI use in older adults.
tinyurl.com/bdhh5kpp
Recent survey study from @journalgim.bsky.social finds low concordance between patients & their GPs with regard to identifying PIMs for #deprescribing.
Explicit discussions considering both patient & GP perspectives are needed for deprescribing success!
Read the full article here:
buff.ly/deJXgyT
Explicit discussions considering both patient & GP perspectives are needed for deprescribing success!
Read the full article here:
buff.ly/deJXgyT
January 18, 2026 at 5:00 PM
Recent survey study from @journalgim.bsky.social finds low concordance between patients & their GPs with regard to identifying PIMs for #deprescribing.
Explicit discussions considering both patient & GP perspectives are needed for deprescribing success!
Read the full article here:
buff.ly/deJXgyT
Explicit discussions considering both patient & GP perspectives are needed for deprescribing success!
Read the full article here:
buff.ly/deJXgyT
🔍 Check out the latest addition to our Deprescribing Guidelines Repository (DEPOT)!
"The Joint Clinical Practice Guideline on Benzodiazepine Tapering" from the American Society of Addiction Medicine provides comprehensive benzodiazepine tapering guidance.
Read more here:
buff.ly/TJOQUBw
"The Joint Clinical Practice Guideline on Benzodiazepine Tapering" from the American Society of Addiction Medicine provides comprehensive benzodiazepine tapering guidance.
Read more here:
buff.ly/TJOQUBw
January 12, 2026 at 5:02 PM
🔍 Check out the latest addition to our Deprescribing Guidelines Repository (DEPOT)!
"The Joint Clinical Practice Guideline on Benzodiazepine Tapering" from the American Society of Addiction Medicine provides comprehensive benzodiazepine tapering guidance.
Read more here:
buff.ly/TJOQUBw
"The Joint Clinical Practice Guideline on Benzodiazepine Tapering" from the American Society of Addiction Medicine provides comprehensive benzodiazepine tapering guidance.
Read more here:
buff.ly/TJOQUBw
🌍 Antihypertensives are among the commonly prescribed medications globally.
Read about a recently-published systematic review & meta-analysis on #deprescribing antihypertensive medications in older people, conducted together with our collaborators here:
buff.ly/CPznF05
Read about a recently-published systematic review & meta-analysis on #deprescribing antihypertensive medications in older people, conducted together with our collaborators here:
buff.ly/CPznF05
January 8, 2026 at 5:01 PM
🌍 Antihypertensives are among the commonly prescribed medications globally.
Read about a recently-published systematic review & meta-analysis on #deprescribing antihypertensive medications in older people, conducted together with our collaborators here:
buff.ly/CPznF05
Read about a recently-published systematic review & meta-analysis on #deprescribing antihypertensive medications in older people, conducted together with our collaborators here:
buff.ly/CPznF05
Read about the thoughts of key global deprescribing stakeholders from the 2024 Australian Deprescribing Network Meeting regarding:
💡 The current landscape of #deprescribing research and practice
‼️ The top future priorities for deprescribing
👉 buff.ly/8e2MMZp
@deprescribeau.bsky.social
💡 The current landscape of #deprescribing research and practice
‼️ The top future priorities for deprescribing
👉 buff.ly/8e2MMZp
@deprescribeau.bsky.social
January 5, 2026 at 5:01 PM
Read about the thoughts of key global deprescribing stakeholders from the 2024 Australian Deprescribing Network Meeting regarding:
💡 The current landscape of #deprescribing research and practice
‼️ The top future priorities for deprescribing
👉 buff.ly/8e2MMZp
@deprescribeau.bsky.social
💡 The current landscape of #deprescribing research and practice
‼️ The top future priorities for deprescribing
👉 buff.ly/8e2MMZp
@deprescribeau.bsky.social
Merry Christmas and Happy Holidays to all from deprescribing.org! ✨
Wishing everyone a safe and joyous holiday season! ❤️
May your holidays be focused on what truly matters - sometimes "less is more" both with prescriptions and with life!
Wishing everyone a safe and joyous holiday season! ❤️
May your holidays be focused on what truly matters - sometimes "less is more" both with prescriptions and with life!
December 25, 2025 at 5:51 PM
Merry Christmas and Happy Holidays to all from deprescribing.org! ✨
Wishing everyone a safe and joyous holiday season! ❤️
May your holidays be focused on what truly matters - sometimes "less is more" both with prescriptions and with life!
Wishing everyone a safe and joyous holiday season! ❤️
May your holidays be focused on what truly matters - sometimes "less is more" both with prescriptions and with life!
Longitudinal cohort study of over 30,000 participants from U.S. National Survey data finds a strong association between PPI users with reduced kidney function and death from any cause.
🚨 Caution is needed when considering PPI use for CKD patients!
Read the full article here:
buff.ly/kTz5275
🚨 Caution is needed when considering PPI use for CKD patients!
Read the full article here:
buff.ly/kTz5275
December 23, 2025 at 5:01 PM
Longitudinal cohort study of over 30,000 participants from U.S. National Survey data finds a strong association between PPI users with reduced kidney function and death from any cause.
🚨 Caution is needed when considering PPI use for CKD patients!
Read the full article here:
buff.ly/kTz5275
🚨 Caution is needed when considering PPI use for CKD patients!
Read the full article here:
buff.ly/kTz5275
As part of the PIP-STOPP study, read about an innovative approach to improve the applicability of the STOPP-START and Beers Criteria for identifying potentially inappropriate medications at a population-level using diagnostic & medication codes!
Find the open-access article here:
buff.ly/QZSFFfh
Find the open-access article here:
buff.ly/QZSFFfh
December 19, 2025 at 5:01 PM
As part of the PIP-STOPP study, read about an innovative approach to improve the applicability of the STOPP-START and Beers Criteria for identifying potentially inappropriate medications at a population-level using diagnostic & medication codes!
Find the open-access article here:
buff.ly/QZSFFfh
Find the open-access article here:
buff.ly/QZSFFfh
Check out ISMP Canada's December 2025 Bulletin describing the collaboration between @deprescribing.bsky.social and Canada's Drug Agency in the development of new tools for patients, care partners, and health providers to combat inappropriate #polypharmacy!
ismpcanada.ca/bulletin/pol...
ismpcanada.ca/bulletin/pol...
December 13, 2025 at 5:34 PM
Check out ISMP Canada's December 2025 Bulletin describing the collaboration between @deprescribing.bsky.social and Canada's Drug Agency in the development of new tools for patients, care partners, and health providers to combat inappropriate #polypharmacy!
ismpcanada.ca/bulletin/pol...
ismpcanada.ca/bulletin/pol...
Congratulations to Armin Farahvash & his team for winning the Dr. John Dupré Award, recognizing the highest ranked resident research poster at the 2025 Diabetes Canada / CSEM Professional Conference!
December 11, 2025 at 10:09 PM
Congratulations to Armin Farahvash & his team for winning the Dr. John Dupré Award, recognizing the highest ranked resident research poster at the 2025 Diabetes Canada / CSEM Professional Conference!
Cohort study published in @jamanetworkopen.com investigated 120 older US veterans who potentially experienced a Gabapentinoid-Loop Diuretic prescribing cascade.
Important findings including the downstream harms of this prescribing cascade can be found in the full article here:
buff.ly/R41BH0Q
Important findings including the downstream harms of this prescribing cascade can be found in the full article here:
buff.ly/R41BH0Q
December 8, 2025 at 5:02 PM
Cohort study published in @jamanetworkopen.com investigated 120 older US veterans who potentially experienced a Gabapentinoid-Loop Diuretic prescribing cascade.
Important findings including the downstream harms of this prescribing cascade can be found in the full article here:
buff.ly/R41BH0Q
Important findings including the downstream harms of this prescribing cascade can be found in the full article here:
buff.ly/R41BH0Q
💡 Large retrospective study finds approximately 1 in 20 nursing home residents who start #gabapentinoids go on to receive a loop diuretic within 3 months.
The study highlights the prevalence of an often overlooked prescribing cascade!
Read the full article here:
buff.ly/5u5O3qh
The study highlights the prevalence of an often overlooked prescribing cascade!
Read the full article here:
buff.ly/5u5O3qh
December 2, 2025 at 5:02 PM
💡 Large retrospective study finds approximately 1 in 20 nursing home residents who start #gabapentinoids go on to receive a loop diuretic within 3 months.
The study highlights the prevalence of an often overlooked prescribing cascade!
Read the full article here:
buff.ly/5u5O3qh
The study highlights the prevalence of an often overlooked prescribing cascade!
Read the full article here:
buff.ly/5u5O3qh
Patient's attitudes towards their medications, information-seeking behaviours, & #deprescribing preferences were studied across 14 different countries 🌍 , with 3 distinct categories of patients found.
Discover detailed insights from the full study here:
buff.ly/lbGyF2c
Discover detailed insights from the full study here:
buff.ly/lbGyF2c
Identifying deprescribing profiles in older adults from 14 countries using the Patient Deprescribing Typology
AbstractBackground and Objectives. Categorizing older adults by their medication and deprescribing beliefs may support tailored communication and shared de
academic.oup.com
November 30, 2025 at 5:00 PM
Patient's attitudes towards their medications, information-seeking behaviours, & #deprescribing preferences were studied across 14 different countries 🌍 , with 3 distinct categories of patients found.
Discover detailed insights from the full study here:
buff.ly/lbGyF2c
Discover detailed insights from the full study here:
buff.ly/lbGyF2c
Great to see our Co-Director Wade Thompson's contribution to a reflective article on Supporting Medication Appropriateness Among Indigenous Peoples in Canada!
Read about the CADeN Indigenization Working Group (IWG) and their learnings in the full article here:
buff.ly/RebVOAX
Read about the CADeN Indigenization Working Group (IWG) and their learnings in the full article here:
buff.ly/RebVOAX
November 26, 2025 at 5:01 PM
Great to see our Co-Director Wade Thompson's contribution to a reflective article on Supporting Medication Appropriateness Among Indigenous Peoples in Canada!
Read about the CADeN Indigenization Working Group (IWG) and their learnings in the full article here:
buff.ly/RebVOAX
Read about the CADeN Indigenization Working Group (IWG) and their learnings in the full article here:
buff.ly/RebVOAX
A Budget Impact Analysis conducted for adult patients using PPIs long-term inappropriately in England, UK 🇬🇧 found an estimated net savings of £11.5 million would be realized over a 5-year period if 20% of patients had their PPI stopped!
Read the full analysis here:
buff.ly/LaRmDOK
@england.nhs.uk
Read the full analysis here:
buff.ly/LaRmDOK
@england.nhs.uk
November 24, 2025 at 5:03 PM
A Budget Impact Analysis conducted for adult patients using PPIs long-term inappropriately in England, UK 🇬🇧 found an estimated net savings of £11.5 million would be realized over a 5-year period if 20% of patients had their PPI stopped!
Read the full analysis here:
buff.ly/LaRmDOK
@england.nhs.uk
Read the full analysis here:
buff.ly/LaRmDOK
@england.nhs.uk
Check out @wypartnership.bsky.social and @england.nhs.uk's new webpage on "Anticholinergic Medicines" and their risks below 👇
www.wypartnership.co.uk/our-prioriti...
Always great to see new resources promoting safe medication use in older adults!
www.wypartnership.co.uk/our-prioriti...
Always great to see new resources promoting safe medication use in older adults!
Anticholinergic medicines :: West Yorkshire Health & Care Partnership
www.wypartnership.co.uk
November 22, 2025 at 4:51 PM
Check out @wypartnership.bsky.social and @england.nhs.uk's new webpage on "Anticholinergic Medicines" and their risks below 👇
www.wypartnership.co.uk/our-prioriti...
Always great to see new resources promoting safe medication use in older adults!
www.wypartnership.co.uk/our-prioriti...
Always great to see new resources promoting safe medication use in older adults!
🎉 Our Fall 2025 Newsletter is now out! 🎉
Learn all about our updates, including new resources, publications, & more:
buff.ly/Pi2BUmf
A heartfelt thanks to all of our team members, partners, & collaborators that helped to spread the word of #deprescribing over the past year! 👏
Learn all about our updates, including new resources, publications, & more:
buff.ly/Pi2BUmf
A heartfelt thanks to all of our team members, partners, & collaborators that helped to spread the word of #deprescribing over the past year! 👏
November 19, 2025 at 5:02 PM
🎉 Our Fall 2025 Newsletter is now out! 🎉
Learn all about our updates, including new resources, publications, & more:
buff.ly/Pi2BUmf
A heartfelt thanks to all of our team members, partners, & collaborators that helped to spread the word of #deprescribing over the past year! 👏
Learn all about our updates, including new resources, publications, & more:
buff.ly/Pi2BUmf
A heartfelt thanks to all of our team members, partners, & collaborators that helped to spread the word of #deprescribing over the past year! 👏
The C-SENIoR Trial, recently published in the Drugs & Aging journal by @springernature.com demonstrates the outcomes of a multifaceted, multidisciplinary intervention on Proton Pump Inhibitor (PPI) #deprescribing!
Read the full article here:
link.springer.com/article/10.1...
Read the full article here:
link.springer.com/article/10.1...
November 16, 2025 at 5:35 PM
The C-SENIoR Trial, recently published in the Drugs & Aging journal by @springernature.com demonstrates the outcomes of a multifaceted, multidisciplinary intervention on Proton Pump Inhibitor (PPI) #deprescribing!
Read the full article here:
link.springer.com/article/10.1...
Read the full article here:
link.springer.com/article/10.1...
Great to see Opioid Deprescribing highlighted in @nejm.org!
Opioid deprescribing through a tailored, patient-centered plan is recommended when the potential harms of opioid therapy outweigh the potential benefits.
Link to the article here:
nej.md/4oL3fu2
@sydney.edu.au
Opioid deprescribing through a tailored, patient-centered plan is recommended when the potential harms of opioid therapy outweigh the potential benefits.
Link to the article here:
nej.md/4oL3fu2
@sydney.edu.au
November 11, 2025 at 5:01 PM
Great to see Opioid Deprescribing highlighted in @nejm.org!
Opioid deprescribing through a tailored, patient-centered plan is recommended when the potential harms of opioid therapy outweigh the potential benefits.
Link to the article here:
nej.md/4oL3fu2
@sydney.edu.au
Opioid deprescribing through a tailored, patient-centered plan is recommended when the potential harms of opioid therapy outweigh the potential benefits.
Link to the article here:
nej.md/4oL3fu2
@sydney.edu.au